Literature DB >> 7437254

Effects of nifedipine on resistance vessels, arteries and veins in man.

B F Robinson, R J Dobbs, C R Kelsey.   

Abstract

1 The effect of nifedipine on peripheral blood vessels has been studied in man. 2 Nifedipine induced dilatation of the forearm resistance vessels when given either by local intra-arterial infusion or sublingually (10 mg). 3 Local infusion of the drug did not relax hand veins preconstricted by infusion of noradrenaline and neither local infusion nor sublingual administration prevented constriction mediated by the sympathetic nervous system. Nifedipine was, however, a potent inhibitor of hand vein contractions induced by high concentrations of potassium provided that the noradrenergic component of the response was suppressed by simultaneous infusion of phentolamine. 4 Sublingual nifedipine (10 mg) did not dilate the elbow collateral arteries. 5 The effects of nifedipine on peripheral blood vessels are similar, but not identical, to those of verapamil. The pattern of action, with dilatation of resistance vessels but not capacitance, resembles that of hydralazine rather than glyceryl trinitrate and this suggest that nifedipine may prove useful in the treatment of hypertension.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7437254      PMCID: PMC1430154          DOI: 10.1111/j.1365-2125.1980.tb01784.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  10 in total

1.  Differential effects of adenosine and nitroglycerin on the action potentials of large and small coronary arteries.

Authors:  D R Harder; L Belardinelli; N Sperelakis; R Rubio; R M Berne
Journal:  Circ Res       Date:  1979-02       Impact factor: 17.367

2.  Responses of inner and outer muscle of the sheep carotid artery to injury.

Authors:  J M Graham; W R Keatinge
Journal:  J Physiol       Date:  1975-05       Impact factor: 5.182

3.  The measurement of volume changes in human limbs.

Authors:  R J WHITNEY
Journal:  J Physiol       Date:  1953-07       Impact factor: 5.182

4.  Prinzmetal's variant form of angina pectoris. Re-evaluation of mechanisms.

Authors:  M Endo; I Kanda; S Hosoda; H Hayashi; K Hirosawa; S Konno
Journal:  Circulation       Date:  1975-07       Impact factor: 29.690

5.  Simplified method for measuring compliance of superficial veins.

Authors:  C Nachev; J Collier; B Robinson
Journal:  Cardiovasc Res       Date:  1971-01       Impact factor: 10.787

6.  Comparison of effects of tolmesoxide (RX71107), diazoxide, hydrallazine, prazosin, glyceryl trinitrate and sodium nitroprusside on forearm arteries and dorsal hand veins of man.

Authors:  J G Collier; R E Lorge; B F Robinson
Journal:  Br J Clin Pharmacol       Date:  1978-01       Impact factor: 4.335

7.  [Electromechanical uncoupling of vascular smooth muscle as the basic principle of coronary dilatation by 4-(2'-nitrophenyl-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid dimethyl ester (BAY a 1040, Nifedipine). 1. The significance of Ca ++ ions for the bioelectrical and mechanical activity of smooth muscle].

Authors:  G Grün; A Fleckenstein
Journal:  Arzneimittelforschung       Date:  1972-02

8.  Verapamil and nifedipine inhibition of contractions induced by potassium and noradrenaline in human mesenteric arteries and veins.

Authors:  E Mikkelsen; K E Andersson; O Lederballe Pedersen
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1979-02

9.  Comparative dilator effect of verapamil and sodium nitroprusside in forearm arterial bed and dorsal hand veins in man: functional differences between vascular smooth muscle in arterioles and veins.

Authors:  B F Robinson; J G Collier; R J Dobbs
Journal:  Cardiovasc Res       Date:  1979-01       Impact factor: 10.787

10.  Nifedipine therapy for Prinzmetal's angina.

Authors:  J E Muller; S J Gunther
Journal:  Circulation       Date:  1978-01       Impact factor: 29.690

  10 in total
  34 in total

1.  Long-term therapy with slow-release nifedipine in essential hypertension.

Authors:  F Arrigo; F Consolo
Journal:  Cardiovasc Drugs Ther       Date:  1990-08       Impact factor: 3.727

2.  Acute effects of nifedipine versus isosorbide dinitrate on exercise tolerance in patients with isolated coronary artery occlusion and collaterals.

Authors:  F Barillà; F Pelliccia; A Valente; C Cianfrocca; F Romeo; A Reale
Journal:  Cardiovasc Drugs Ther       Date:  1990-08       Impact factor: 3.727

Review 3.  Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.

Authors:  E M Sorkin; S P Clissold; R N Brogden
Journal:  Drugs       Date:  1985-09       Impact factor: 9.546

Review 4.  Future Treatment of Hypertension: Shifting the Focus from Blood Pressure Lowering to Arterial Stiffness Modulation?

Authors:  Henry Fok; J Kennedy Cruickshank
Journal:  Curr Hypertens Rep       Date:  2015-08       Impact factor: 5.369

5.  The potassium channel opening drug cromakalim produces arterioselective vasodilation in the upper limbs of healthy volunteers.

Authors:  D J Webb; N Benjamin; P Vallance
Journal:  Br J Clin Pharmacol       Date:  1989-06       Impact factor: 4.335

6.  Intracellular calcium and blood pressure: comparison between primary hyperparathyroidism and essential hypertension.

Authors:  C Fardella; J A Rodriguez-Portales
Journal:  J Endocrinol Invest       Date:  1995-12       Impact factor: 4.256

7.  Treatment of angina pectoris with nifedipine and atenolol: efficacy and effect on cardiac function.

Authors:  I N Findlay; K MacLeod; M Ford; G Gillen; A T Elliott; H J Dargie
Journal:  Br Heart J       Date:  1986-03

Review 8.  Calcium antagonists in cerebral/peripheral vascular disorders. Current status.

Authors:  K J Tietze; M L Schwartz; P H Vlasses
Journal:  Drugs       Date:  1987-06       Impact factor: 9.546

9.  Vasodilatory effect of nicardipine and verapamil in the forearm of hypertensive as compared with normotensive man.

Authors:  U L Hulthén; P Bolli; F R Bühler
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

10.  Haemodialysis does not affect the pharmacokinetics of nifedipine.

Authors:  H Martre; R Sari; A M Taburet; C Jacobs; E Singlas
Journal:  Br J Clin Pharmacol       Date:  1985-08       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.